A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Xylazine
This training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
 |
Wednesday, 3/29/2023 3:00 pm – 4:00 pm ET |
 |
Virtual event |
 |
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 4/12/2023 5:00 pm – 6:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of skin wounds with chronic exposure. We will discuss how these wounds may present themselves among those using substances with xylazine, harm reduction best practices, and ways they are currently being treated in the hospitals and community setting.
|
Thursday, 4/27/2023 5:00 pm – 6:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 5/24/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 6/14/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Thursday, 7/20/2023 11:00 am – 12:00 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of skin wounds with chronic exposure. We will discuss how these wounds may present themselves among those using substances with xylazine, harm reduction best practices, and ways they are currently being treated in the hospitals and community setting.
|
Wednesday, 9/13/2023 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 9/13/2023 3:00 pm – 4:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Friday, 10/6/2023 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 11/8/2023 2:00 pm – 3:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.